CN
CN Bio Innovations
Oxford UKFounded 200980 employees
Private CapbiotechPrivateOncology
Platform: Organ-on-Chip
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| CN-9071 | CN-9071 | Preclinical | 2 | WRN | MelanomaSchizophrenia | ||
| CN-8014 | CN-8014 | Phase 2/3 | 2 | Aβ | CLLWilms |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)